COVID-19 medtech recovery and impact on account engagement

The pandemic has drastically impacted commercial activities across the medtech market. Deferred elective procedures and limited access to healthcare settings and providers have upended account planning and engagement tactics, and many commercial teams are using this as an opportunity to revisit their strategy and the customers they should prioritize. How are medtech commercial teams updating their strategies and tactics to stay ahead?

In this webinar, Roman Eguzhov (National Sales Manager) from Boston Scientific and Clarivate’s commercial targeting product manager Jason Lau will discuss:

• The lasting impact of COVID-19 on medtech commercial activities and the road to market recovery
• New considerations for account targeting and existing resources to drive decision-making
• Evolving engagement models, strategies and channels